Pair Name | Quercetin, Fluorouracil | ||
Phytochemical Name | Quercetin (PubChem CID: 5280343 ) | ||
Anticancer drug Name | Fluorouracil (PubChem CID: 3385 ) | ||
Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
Drug Name | Fluorouracil |
Adverse Reactions | Application site erythema, application site pruritus. This was inferred hot nature anticancer drug. |
Recommendations | Cold: Pueraria thomsonii; Bupleurum scorzonerifolium; Pueraria thomsonii; Pueraria edulis |
Reference | Traditional Chinese medicine characteristics of chemotherapy regimens in advanced gastrointestinal malignant tumours[J]. Global Traditional Chinese Medicine,2023,16(8):1596-1599. DOI:10.3969/j.issn.1674-1749.2023.08.019. ref_link |
Pair Name | Quercetin, Fluorouracil | |||
Disease Info | [ICD-11: 2B90] | Colon cancer | Investigative | |
In Vitro Model | HT-29 | Colon adenocarcinoma | Homo sapiens (Human) | CVCL_0320 |
In Vivo Model | Rats were assigned to two groups. The 5-FU/quercetin group received intraperitoneal quercetin (10 mg/kg) and the Tween was injected to the control group for 14 consecutive days. On the 15th day, both groups received 50 mg/kg of 5-FU. | |||
Result | Interaction of quercetin and 5-fluorouracil: cellular and pharmacokinetic study |
Pair Name | Quercetin, Fluorouracil | |||
Disease Info | [ICD-11: 2B90] | Colon cancer | Investigative | |
Biological Phenomena | Induction-->Apoptosis | |||
Gene Regulation | Down-regulation | Expression | HMOX1 | hsa3162 |
Down-regulation | Expression | NFE2L2 | hsa4780 | |
In Vitro Model | HCT 116 | Colon carcinoma | Homo sapiens (Human) | CVCL_0291 |
Result | Our results suggest that Que reverses 5-FU resistance in CC cells via modulating the Nrf2/HO-1 pathway. |
No. | Title | Href |
---|---|---|
1 | Interaction of quercetin and 5-fluorouracil: cellular and pharmacokinetic study. Toxicol Mech Methods. 2023 Nov;33(6):502-511. doi: 10.1080/15376516.2023.2188928. | Click |
2 | Quercetin reverses 5-fluorouracil resistance in colon cancer cells by modulating the NRF2/HO-1 pathway. Eur J Histochem. 2023 Aug 7;67(3):3719. doi: 10.4081/ejh.2023.3719. | Click |